Get startedLog in
    Picture of Sanofi SA logo

    SAN — Sanofi SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    All News

    Brief: Sanofi, pCPA Sign Letter Of Intent For Dupixent® Across Four Indications In Dermatology, Respiratory Care

    Picture of Sanofi SA logoSanofi SA
    15/10/2026 17:04
    BRIEF-Sanofi, pCPA Sign Letter Of Intent For Dupixent® Across Four Indications In Dermatology, Respiratory Care
    Oct 15 (Reuters) - Sanofi SA SASY.PA:
    • SANOFI AND PCPA SIGN LETTER OF INTENT FOR DUPIXENT® ACROSS FOUR INDICATIONS IN DERMATOLOGY AND RESPIRATORY CARE
    • TO SUPPORT PATIENT ACCESS TO DUPIXENT VIA PUBLIC DRUG PLANS IN CANADA
    Source text: ID:nCNWr53dFa
    Further company coverage: SASY.PA

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Sanofi SA

    See all news